Interactions of Bovine Respiratory Syncytial Virus with Cattle: Understanding Pathogenesis and Immune Responses

Fischer Silva^*
*Correspondence: Fischer Silva, Department of Veterinary Pathobiology, Oklahoma State University, Stillwater, OK 74078, USA, Email:

Introduction

The clinical symptoms of BRSV infection in cattle can range from mild to severe. In mild cases, calves may exhibit mild respiratory signs, such as coughing and nasal discharge, but may recover with minimal intervention. However, in more severe cases, particularly in young calves or those with pre-existing respiratory conditions, the disease can progress rapidly to pneumonia, hypoxemia (low oxygen levels in the blood), and respiratory failure. Secondary bacterial infections are common in these severe cases, further complicating the disease course and increasing the risk of death. Bovine Respiratory Syncytial Virus is a significant pathogen in cattle, particularly affecting young animals and those in intensive farming environments. It is a major cause of bovine respiratory disease, a multifactorial condition that leads to substantial economic losses in the cattle industry worldwide. BRSV primarily affects the respiratory system, leading to severe clinical symptoms such as coughing, nasal discharge, labored breathing, and even death in severe cases. Understanding the interactions between BRSV and its host, cattle, is crucial for the development of effective preventive and therapeutic measures. BRSV belongs to the Paramyxoviridae family and the Pneumovirus genus, and it shares many similarities with respiratory syncytial virus in humans. However, the pathogenesis and immune responses in cattle infected with BRSV differ in significant ways. Despite being recognized as a key viral pathogen for decades, many aspects of the virus's interactions with cattle, including its ability to evade immune responses and the long-term effects of infection, remain unclear [1,2].

Description

This article explores the pathogenesis of BRSV infection in cattle, its impact on the respiratory system, and the immune responses that are activated during infection. It also discusses the challenges in controlling the disease and the potential for future research in improving the prevention and treatment of BRSV infections in cattle. Bovine Respiratory Syncytial Virus primarily infects the upper and lower respiratory tract of cattle, leading to a range of clinical outcomes from mild to severe disease. The virus primarily affects calves and young cattle but can also infect older animals, particularly those with compromised immune systems or existing respiratory conditions. BRSV enters the body through the nasal or oral mucosa when an animal inhales respiratory droplets containing the virus. Upon entry, the virus targets the epithelial cells of the upper respiratory tract, including the nasal mucosa, trachea, and bronchi. The virus attaches to host cells through the fusion and attachment glycoproteins on its surface, which mediate the binding of the virus to cell receptors. This interaction triggers the fusion of the viral envelope with the host cell membrane, allowing the virus to release its genetic material into the host cell. Once inside the host cell, BRSV replicates in the cytoplasm, leading to the production of new viral particles. These viral particles then infect neighboring cells, and the infection spreads throughout the respiratory tract [3-5].

Conclusion

Bovine Respiratory Syncytial Virus is a major pathogen of cattle, causing significant respiratory disease and economic losses in the livestock industry. The virus’s ability to infect the respiratory tract, evade the immune system, and induce both viral and immune-mediated tissue damage makes it a challenging pathogen to control. Understanding the interactions between BRSV and the immune system is crucial for the development of more effective vaccines and therapeutic interventions. While research on BRSV continues to advance, significant challenges remain in the prevention, diagnosis, and treatment of BRSV infections in cattle. Improved vaccine development, antiviral therapies, and management practices are needed to reduce the burden of BRSV in cattle populations. Management of the disease primarily involves supportive care, such as providing oxygen therapy and administering antibiotics to treat secondary bacterial infections.

Acknowledgement

None.

Conflict of Interest

None.

References

1. Paccaud, M. F., and C. L. Jacquier. "A respiratory syncytial virus of bovine origin." Arch Virol Res 30 (1970): 327-342.

Google Scholar, Crossref, Indexed at

2. Rosenquist, Bruce D. "Isolation of respiratory syncytial virus from calves with acute respiratory disease." J Infect Dis 130 (1974): 177-182.

Google Scholar, Crossref, Indexed at

3. Hägglund, Sara, Katarina Näslund, Anna Svensson and Cecilia Lefverman, et al. "Longitudinal study of the immune response and memory following natural bovine respiratory syncytial virus infections in cattle of different age." Plos one 17 (2022): 274-332.

Google Scholar, Crossref, Indexed at

4. Hoppe, Ingrid Bortolin Affonso Lux, Andréa Souza Ramos de Medeiros, Clarice Weis Arns and Samir Issa Samara. "Bovine respiratory syncytial virus seroprevalence and risk factors in non-vaccinated dairy cattle herds in Brazil."    BMC Vet Res 14 (2018): 1-6.

Google Scholar, Crossref, Indexed at

5. Hussain, Khder Jassiem, Maab Ibrahim Al-Farwachi and Sadam Dhahir Hassan. "Seroprevalence and risk factors of bovine respiratory syncytial virus in cattle in the Nineveh Governorate, Iraq." Vet World 12 (2019): 1862.

Google Scholar, Crossref, Indexed at